Complement Factor MASP3/MASP1 Products

Description

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Bioinformatics

Product By Gene ID

5648

Alternate Names

Complement Factor MASP3 Complement factor MASP-3 Complement-activating component of Ra-reactive factor CRARF1 CRARFMAP1 DKFZp686I01199 EC 3.4.21 EC 3.4.21.- EC 3.4.21.104 EC 3.4.21.42 FLJ26383 mannan-binding lectin serine peptidase 1 (C4/C2 activating component ofRa-reactive factor) mannan-binding lectin serine protease 1 (C4/C2 activating component ofRa-reactive factor) mannan-binding lectin serine protease 1 Mannose-binding lectin-associated serine protease 1 Mannose-binding protein-associated serine protease MAp44 MASP MASP1 MASP-1 MASP3 MGC126283 MGC126284 PRSS5 Ra-reactive factor serine protease p100 RaRF Serine protease 5